bioRxivCancer Biology
GABA(A) receptor activation drives GABARAP-Nix mediated autophagy to radiation-sensitize primary and brain-metastatic lung adenocarcinoma tumors
D. Bhatacharya, R. Barille, D. K. Toukam, V. S. Gawali, L. Kallay, T. Ahmed, H. Brown, S. Rezvanian, A. Karve, P. B. Desai, M. Medvedovic, K. Wang, D. Ionascu, N. Harun, C. Wang, A. M. Baschnagel, J. A. Kritzer, J. M. Cook, D. P. Krummel, S. Sengupta
Abstract
In non-small cell lung cancer (NSCLC) treatment, targeted therapies benefit only a subset of NSCLC, while radiotherapy responses are not durable and toxicity limits therapy. We find that a GABA(A) receptor activator, AM-101, impairs viability and clonogenicity of NSCLC primary and brain metastatic cells. Employing an ex vivo chip, AM-101 is as efficacious as the chemotherapeutic docetaxel, which is used with radiotherapy for advanced-stage NSCLC. In vivo, AM-101 potentiates radiation, including conferring a survival benefit to mice bearing NSCLC intracranial tumors. GABA(A) receptor activation stimulates a selective-autophagic response via multimerization of GABA(A) Receptor-Associated Protein (GABARAP), stabilization of mitochondrial receptor Nix, and utilization of ubiquitin-binding protein p62. A targeted-peptide disrupting Nix binding to GABARAP inhibits AM-101 cytotoxicity. This supports a model of GABA(A) receptor activation driving a GABARAP-Nix multimerization axis triggering autophagy. In patients receiving radiotherapy, GABA(A) receptor activation may improve tumor control while allowing radiation dose de-intensification to reduce toxicity. HighlightsO_LIActivating GABA(A) receptors intrinsic to lung primary and metastatic brain cancer cells triggers a cytotoxic response. C_LIO_LIGABA(A) receptor activation works as well as chemotherapeutic docetaxel in impairing lung cancer viability ex vivo. C_LIO_LIGABA(A) receptor activation increases survival of mice bearing lung metastatic brain tumors. C_LIO_LIA selective-autophagic response is stimulated by GABA(A) receptor activation that includes multimerization of GABARAP and Nix. C_LIO_LIEmploying a new nanomolar affinity peptide that abrogates autophagosome formation inhibits cytotoxicity elicited by GABA(A) receptor activation. C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/569295v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1df2f4eorg.highwire.dtl.DTLVardef@19ac26forg.highwire.dtl.DTLVardef@1533986org.highwire.dtl.DTLVardef@e59653_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- GABA-GABA_A Receptor Signaling Orchestrates Invasion and Metastasis in Triple Negative Breast Cancer
Esther Afolayan, Boxon Zhang, … Karla C. Williams·bioRxiv·Oct 3, 2025
- Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology
Durgesh Meena, Divya Shivakumar, … Sushmita Jha·Journal of Cellular PhysiologyPeer-reviewed·Mar 1, 2026
- Patient-derived glioblastoma neurosphere cultures differentially express nicotinic acetylcholine receptors depending on ambient choline
Elena A. Gondarenko, Diana V. Mazur, … Н. В. Антипова·bioRxiv·Apr 6, 2023
- BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy
Shivani Thoidingjam, Sushmitha Sriramulu, … Shyam Nyati·CancersPeer-reviewed·Sep 27, 2024
- Rac1 and CHK1 Converge on Abi-1 to Regulate DNA Repair Dependency and Treatment Response in Human Cancers
Yiheng Huang, Elizabeth C. McCulla, … Weihua Zhou·bioRxiv·Sep 18, 2026
- Radiosensitization of Glioblastoma by the K-ras Inhibitor RMC-6236
Hong Shik Yun, Tamalee R. Kramp, … Kevin A. Camphausen·bioRxiv·Jun 2, 2026